Solstein Capital, LLC Astrazeneca PLC Transaction History
Solstein Capital, LLC
- $185 Million
- Q4 2024
A detailed history of Solstein Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Solstein Capital, LLC holds 19 shares of AZN stock, worth $1,292. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19
Previous 19
-0.0%
Holding current value
$1,292
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,376Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.1 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.79 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.55 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.63 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.32 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...